In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fisher Scientific International Inc.

http://www.fisherscientific.com

Latest From Fisher Scientific International Inc.

Deal Statistics Quarterly, Q2 2006

In this issue, we present another installment of our quarterly review of dealmaking-for April-June 2006. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.

BioPharmaceutical Medical Device

Post-Macugen, Still In-Licensing to Uncover Value in Ophthalmology

The lesson that entrepreneurs and VCs seem to be taking from the fast-paced ophthalmology sector is the need for shorter development time frames and clinical candidates with reduced risk. Among others, MacuSight, Danube, and Lux, profiled here, are to one extent or another revisiting the existing pharmacopeia to test ophthalmic indications for existing compounds.

BioPharmaceutical Strategy

Deal Statistics Quarterly, Q1 2006

In this issue, we present another installment of our quarterly review of dealmaking-for January-March 2006. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.

BioPharmaceutical Medical Device

Molecular Diagnostics--From Tools to Tests

Instrument makers have made big money off the genomics revolution. But as the research market slows, companies are looking for new business opportunities. One area ripe for development: the molecular diagnostics market.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
UsernamePublicRestriction

Register